Fixed-effects model showed the expression of B7-H3 was associated with 24-month overall survival in CRC patients (Fixed-effects, OR=0.48, 95% CI: 0.32–0.74, P<0.001) (Fig.3). The gene discussed is CD276; the disease is colorectal carcinoma.